angiotensin ii has been researched along with Coronary Disease in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (40.79) | 18.7374 |
1990's | 55 (36.18) | 18.2507 |
2000's | 29 (19.08) | 29.6817 |
2010's | 3 (1.97) | 24.3611 |
2020's | 3 (1.97) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Fang, X; Guo, D; Hu, Y; Li, X; Zhang, F; Zhou, H | 1 |
Dang, R; Feng, Q; Geng, C; Guo, Y; Han, W; Jiang, P; Wang, C; Wei, Z; Zhang, H | 1 |
Etchegoyen, M; Otero-Losada, M | 1 |
Abd El-Aziz, TA; Mohamed, RH; Rezk, NA | 1 |
Chen, JW; Chen, Z; Chien, S; Fang, L; Geary, GG; Geary, MJ; Hsu, CY; Huang, HD; Huang, PH; Johnson, DA; Lin, FM; Lin, SJ; Lin, TY; Martin, M; Miller, YI; Shyy, JY; Wen, L; Zhao, Y | 1 |
Maslov, LN; Naryzhnaia, NV | 1 |
Anguita Sánchez, M | 1 |
Delyani, J; Martin-Berger, CL; McMahon, E; Rocha, R; Scherrer, R; Yang, P | 1 |
An, HY; Huang, LJ; Jin, JS | 1 |
Li, QZ; Nie, S; Ye, HJ; Zhao, SP; Zhou, HN | 1 |
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU | 1 |
Ardell, JL; Armour, JA; Cardinal, R; Foreman, RD; Linderoth, B; Vermeulen, M | 1 |
Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Mishima, T; Nakai, Y; Sobel, BE; Zaman, AK | 1 |
Pitt, B | 1 |
Hemels, ME; Van den Berg, MP; Van Gelder, IC; Van Tintelen, JP; Van Veldhuisen, DJ; Wiesfeld, AC | 1 |
Bolad, I; Delafontaine, P | 1 |
Pool, JL | 1 |
Campbell, DJ; Chirkov, YY; Horowitz, JD; Rajendran, S | 1 |
Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW | 1 |
Devereux, RB; Krauser, DG | 1 |
Bertrand, M; Blann, A; Ceconi, C; Cokkinos, D; Ferrari, R; Fox, KM; Kluft, C; Parrinello, G; Remme, WJ; Simoons, ML | 1 |
Drexler, H; Fischer, D; Landmesser, U; Manes, C; Mueller, M; Preuss, C; Sorrentino, S; Spiekermann, S | 1 |
Dusting, GJ; Martin, TJ; Nolan, RD; Woodman, OL | 1 |
Punzengruber, C; Silberbauer, K; Sinzinger, H | 1 |
Galli, M; Manca, C; Maresta, A; Mazzocchi, A; Parodi, O; Specchia, G; Tavazzi, L | 1 |
Biryńczyk, J; Kostka-Wach, M; Lehmann, Z; Stasiński, T; Warenik-Szymankiewicz, A | 1 |
Bove, AA; Carey, R; Santamore, WP; Spann, JF; Walinsky, P | 1 |
Bianco, JA; Laskey, WK; Makey, DG; Shafer, RB | 2 |
Altura, BM; Turlapaty, PD | 1 |
Dzau, VJ; Gibbons, GH; Pratt, R | 1 |
Janicki, JS; Reddy, HK; Sigusch, H; Tyagi, SC; Weber, KT; Zhou, G | 1 |
Bloom, SR; Clark, P; Cleland, JG; Crossman, D; Ghatei, MA; Good, JM; Nihoyannopoulos, P; Oakley, CM | 1 |
Baur, LH; Cats, VM; de Groot, A; Frölich, M; Keirse, MJ; Schipperheyn, JJ; Souverijn, JH; van der Laarse, A; Voogd, PJ; Vroom, TF | 1 |
Pessina, AC; Rossi, G | 1 |
Falkenhahn, M; Gohlke, P; Paul, M; Stoll, M; Unger, T | 1 |
Lüscher, TF | 2 |
Fish, AF | 1 |
McInnes, GT | 1 |
Pitt, B; Timmis, AD | 1 |
Dzau, VJ | 3 |
Fenwick, MK; Morton, JJ; Motwani, JG; Struthers, AD | 1 |
Gavras, H | 1 |
Bootsma, M; de Leeuw, PW; Kruyssen, DA; Look, MP; Remme, WJ | 1 |
Swales, JD | 1 |
Campa, PP | 1 |
Furukawa, Y; Hirozane, T; Matsumori, A; Sasayama, S | 1 |
Deng, H; Guo, H; Qian, X | 1 |
Acker, WR; Chang, RS; Drag, MD; Fujita, T; Greenlee, WJ; Holder, DJ; Huckle, WR; Johnson, RG; Kim, D; Mantlo, NB; McFall, RC; Ondeyka, DL; Powers, M; Reilly, CF; Schwartz, RS; Stabilito, II | 1 |
Dzau, VJ; Pratt, RE | 1 |
Fleck, E; Hildebrandt, A; Neuss, M; Regitz-Zagrosek, V | 1 |
Burkart, F; de Gasparo, M; Eberhard, M; Erne, P; Graedel, E; Rogg, H; Stulz, P | 1 |
Krasnikova, TL | 1 |
Cambien, F | 1 |
Riegger, GA | 1 |
Di Francesco, L; Mancia, G; Perondi, R; Pomidossi, G; Rimini, A; Saino, A; Valentini, R | 1 |
Choi, Y; Choo, JA; Gwon, HC; Huh, JE; Kim, DK; Kim, JW; Kim, S; Lee, WR; Rhee, CH; Ryu, JC | 1 |
Brockhoff, C; Heitzer, T; Just, H; Meinertz, T; Münzel, T; Olschewski, M | 1 |
Gibbons, GH | 1 |
Drexler, H; Hornig, B | 1 |
Cheng, TO | 1 |
Liu, H; Wang, J | 1 |
Mélon, P | 1 |
Swedberg, KB | 1 |
Komatsu, R; Ueda, M | 1 |
Dietz, R; Gross, M; Gulba, D; Krämer, J; Osterziel, KJ; von Harsdorf, R; Willenbrock, R | 1 |
Gardemann, A; Haberbosch, W; Hehrlein, FW; Humme, J; Katz, N; Nguyen, QD; Rau, M; Stricker, J; Tillmanns, H | 1 |
Burkhoff, D; Gu, AG; Popilskis, S; Wang, J; Yi, GH; Zhang, H; Zhu, SM | 1 |
Bartels, GL; Remme, WJ; van den Heuvel, FM; van der Ent, M; van Veldhuisen, DJ | 1 |
Egashira, K; Takemoto, M | 1 |
Foy, CA; Grant, PJ; Rice, GI | 1 |
Hashimoto, K; Sugiyama, A; Takehana, S | 1 |
Braith, RW; Feigenbaum, MS; Kluess, HA; Pepine, CJ; Welsch, MA | 1 |
Cheung, PK; Saward, L; Wilson, DP; Zahradka, P | 1 |
Drexler, H; Wollert, KC | 1 |
Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
Deedwania, PC | 1 |
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J | 1 |
Marchini, F; Morazzoni, G; Papp, JG; Parratt, JR; Rastegar, MA; Vegh, A | 1 |
Berg, GA; Berry, C; Brosnan, MJ; Dominiczak, AF; Hamilton, CA; Magill, FG; McMurray, JJ | 1 |
Edgington, TS | 1 |
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Gulba, D; Haller, H; Luft, FC; Luther, T; Mackman, N; Mervaala, EM; Müller, DN; Park, JK; Schmidt, F; Schneider, W; Theuer, J | 1 |
August, P; Leventhal, B; Suthanthiran, M | 1 |
Grabs, R; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M | 1 |
Borland, JA; Chester, AH; Yacoub, MH | 1 |
Eleuteri, E | 1 |
Asada, K; Jin, D; Kondo, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sawada, Y; Takai, S; Yamada, M; Yuda, A | 1 |
Alexander, JK; Gaasch, WH; Quinones, MA; Thiel, HG; Waisser, E | 1 |
Hollander, W | 1 |
Rachinskiĭ, ID | 1 |
Cipressi, F; Mattioli, G; Nardini, M; Zennaro, R | 2 |
Genova, R; Mattioli, G; Nardini, M; Zennaro, R | 1 |
Cipressi, F; Genova, R; Mattioli, G; Zennaro, R | 2 |
Grossi, R; Mattioli, G; Nardini, M; Zennaro, RG | 1 |
Ledingham, IM | 1 |
Johnson, SP; Schoeneberger, AA; Sullivan, JM | 1 |
Da Luz, PL; Forrester, JS; Swan, HJ; Waters, DD; Wyatt, HL | 1 |
Hintze, TH; Kaley, G | 1 |
Maxwell, MH; Varady, P | 1 |
Col, J; Pouleur, H | 1 |
Crexells, C; Diamond, G; Forrester, JS; Parmley, WW; Tomoda, H | 1 |
Cochran, PT; Ronan, JA; Schrank, JP; Steelman, RB | 1 |
Shushliapin, OI; Vlasenko, MA | 1 |
Kravchun, PG; Mikliaev, IIu; Rachinskiĭ, ID; Shushliapin, OI; Vlasenko, MA | 1 |
Davies, E; Edwards, CR; Flapan, AD; Rademaker, M; Shaw, TR; Williams, BC | 1 |
de Jong, JW; Huizer, T; van der Meer, P | 1 |
Alessio, P; Gregorini, L; Mancia, G; Morganti, A; Perondi, R; Pomidossi, G; Saino, A; Tio, RA; Zanchetti, A | 1 |
Gessner, C; Hain, P; Mitrovic, V; Müller, KD; Schlepper, M | 1 |
Apstein, CS; Eberli, FR; Lorell, BH; Mochizuki, T | 1 |
Ertl, G; Haas, U; Neubauer, S; Pulzer, F; Tian, R | 1 |
Malinovskaia, IE; Popova, LI; Reĭko, MN; Savitskiĭ, SIu; Shumakov, VA; Tashchuk, VK | 1 |
Bauer, B; Ertl, G | 1 |
Heusch, G; Linder, C | 1 |
Bel, KJ; de Graeff, PA; de Langen, CD; Kingma, JH; van Gilst, WH; Wesseling, H | 1 |
Arakawa, K; Gondo, M; Maruta, H | 1 |
Linz, W; Schölkens, BA | 1 |
Inukai, T; Nakao, K; Yamamoto, S | 1 |
Fernandes, A | 1 |
Asayama, J; Azuma, A; Furukawa, K; Inagaki, S; Katahira, T; Katsume, H; Kubota, Y; Nakagawa, T; Shiga, K; Sugihara, H | 1 |
Fukuzaki, H; Hayashi, T; Takeuchi, M | 1 |
Abrahamsson, T; Carlsson, L | 1 |
Chardigny, JM; Diebold, H; Moreau, D; Rochette, L | 1 |
Ganten, D; Gohlke, P; Lang, RE; Unger, T | 1 |
Blaine, EH; Frederick, CM; Ludden, CT; Nussberger, J; Ribeiro, LG; Slater, EE; Sweet, CS | 1 |
Albus, U; Breipohl, G; Knolle, J; Linz, W; Petry, P; Schölkens, BA | 1 |
De Graeff, PA; De Langen, CD; Kingma, JH; Van Gilst, WH; Wesseling, H | 1 |
Goto, A; Ishiguro, M; Matsuno, Y; Miyake, H; Morita, N; Sawa, H; Sugishita, N; Sugiyama, A; Sumita, Y; Watanabe, S | 1 |
Gemperle, M; Megevand, R; Moret, PR | 1 |
Cardini, G; Clemente, R; Riggio, G | 1 |
Accatino, G; Campus, S; Pandolfo, G; Rappelli, A | 1 |
Clemente, R; Riggio, G | 1 |
Serebrovskaia, IuA; Uchitel', IA; Vinogradov, AV | 1 |
Ezhow, JS; Kowanew, WA | 1 |
Barold, SS; Hildner, FJ; Linhart, JW; Samet, P | 1 |
Becker, KH; Lorenz, D | 1 |
Parratt, JR | 1 |
Bretschneider, HJ; Grebe, D; Kübler, W; Orellano, LE; Spieckermann, PG | 1 |
Iimura, O; Miyahara, M | 1 |
Cabades, A; de Castro, O; Delaye, J; Gonin, A; Pourchaire, J | 1 |
Horwitz, LD; Mullins, CB; Payne, RM | 1 |
Hellstrom, HR | 1 |
Wilson, WJ; Wolf, GL | 1 |
Conti, CR; Horvath, JS; Mitch, WE; Moore, MA; Russell, RP; Walker, WG | 1 |
Chaudhuri, AK; Das, G; De, MS; Ghosh, A; Hazra, S | 1 |
Branche, G; Chiles, B; Garnier, C; Kilcoyne, MM; Soland, T; Thomson, GE; Williams, M | 1 |
Demanet, JC; Verniory, A | 1 |
Gaasch, WH; Hernandez-Lattuf, PR; Quinones, MA | 1 |
35 review(s) available for angiotensin ii and Coronary Disease
Article | Year |
---|---|
[Prevention and treatment of congestive heart failure in diabetic patients].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Meta-Analysis as Topic; Metoprolol; Prognosis; Propanolamines; Risk Factors; Time Factors | 2002 |
Genetic aspects of atrial fibrillation.
Topics: Aged; Angiotensin II; Atrial Fibrillation; Connexins; Coronary Disease; Gap Junction alpha-5 Protein; Heart Conduction System; Heart Failure; Humans; Polymorphism, Genetic | 2005 |
Endothelial dysfunction: its role in hypertensive coronary disease.
Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants | 2005 |
The role of angiotensin II in hypertension and end-organ damage.
Topics: Angiotensin II; Animals; Arteriosclerosis; Coronary Disease; Diabetes Complications; Humans; Hypertension; Kidney Diseases | 2000 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Coronary Disease; Female; Humans; Hypertension; Renin; Stimulation, Chemical; Thrombosis | 1980 |
Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Heart; Heart Failure; Humans; Myocardial Contraction; Renin-Angiotensin System; Ventricular Dysfunction, Left | 1994 |
[Molecular biology and cardiac and vascular changes in hypertension: focus on the renin-angiotensin system].
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Coronary Disease; Female; Genetic Markers; Humans; Hypertension; Hypertension, Renal; Male; Mice; Mice, Inbred DBA; Mice, Transgenic; Middle Aged; Prospective Studies; Rats; Renin-Angiotensin System; Risk Factors | 1994 |
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1994 |
Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Disease; Heart; Humans; Hyperplasia; Hypertension; Muscle Development; Muscle, Smooth, Vascular; Tunica Intima | 1994 |
Role of ACE inhibitors in hypertension complicated by vascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Humans; Hypertension; Peripheral Vascular Diseases | 1994 |
Effects of ACE inhibitors on coronary atherosclerosis and restenosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Recurrence; Renin-Angiotensin System; Ventricular Dysfunction, Left | 1994 |
Cell biology and genetics of angiotensin in cardiovascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiovascular Diseases; Cell Division; Coronary Disease; Humans; Vascular Diseases; Ventricular Function | 1994 |
Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Clinical Trials as Topic; Coronary Disease; Heart; Humans; Multicenter Studies as Topic; Risk Factors | 1994 |
[The coronary circulation, renin-angiotensin system and ACE inhibition].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Coronary Disease; Humans; Myocardial Ischemia; Renin-Angiotensin System | 1995 |
[Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Imidazoles; Kidney Diseases; Losartan; Myocardial Infarction; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors | 1996 |
Insight into the genetic epidemiology of coronary heart disease.
Topics: Alcohol Drinking; Angiotensin II; Cholesterol, HDL; Coronary Disease; Fibrinogen; Humans; Polymorphism, Genetic; Risk Factors; Smoking | 1996 |
Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Coronary Disease; Humans; Hypertension; Morbidity; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors | 1996 |
Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Humans; Microcirculation; Myocardium; Nitric Oxide; Reactive Oxygen Species; Vascular Resistance; Vasodilation | 1997 |
Endothelial function and bradykinin in humans.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Coronary Disease; Endothelium, Vascular; Humans; Hypertension; Myocardial Ischemia; Nitric Oxide; Renin-Angiotensin System | 1997 |
Impact of neuroendocrine activation on coronary artery disease.
Topics: Angiotensin II; Coronary Disease; Coronary Vessels; Endothelins; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Neurosecretory Systems; Renin-Angiotensin System; Vasoconstriction | 1998 |
[Plaque progression and destabilization in human coronary arteries].
Topics: Acute Disease; Angiotensin II; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Endothelial Growth Factors; Humans; Lymphokines; Peptidyl-Dipeptidase A; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Mechanism of protective effects of ACE inhibition on coronary artery disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Disease; Humans; Peptidyl-Dipeptidase A; Prognosis | 1998 |
Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death.
Topics: Angiotensin II; Coronary Disease; Death, Sudden, Cardiac; Heart Failure; Humans; Models, Cardiovascular | 1998 |
[Vascular remodeling and angiotensin II].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Disease; Humans; Neovascularization, Pathologic; Recurrence | 1999 |
The renin-angiotensin system and experimental heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Cardiomegaly; Coronary Disease; Heart Failure; Mice; Mice, Transgenic; Myocardium; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 1999 |
Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Disease; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Linear Models; Prevalence; Stroke; Transforming Growth Factor beta; White People | 2000 |
The renin angiotensin system in bypass graft surgery.
Topics: Angiotensin II; Animals; Coronary Artery Bypass; Coronary Disease; Endothelium, Vascular; Humans; Muscle Contraction; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 2000 |
Role of hypertension in atherosclerosis and cardiovascular disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis | 1976 |
Heart failure in experimental refractory shock.
Topics: Angiotensin II; Animals; Catecholamines; Coronary Disease; Endotoxins; Gastrointestinal Hemorrhage; Heart; Heart Failure; Heart Ventricles; Peptides; Shock, Hemorrhagic | 1976 |
ACE inhibitors for the treatment of myocardial ischemia?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Humans | 1990 |
[Physiopathology of arterial hypertension. Significance of the renin-angiotensin-aldosterone system and structural changes].
Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Humans; Hypertension; Hypertrophy; Renin-Angiotensin System | 1989 |
[The renin-angiotensin system: systemic and local function].
Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1988 |
Pharmacological aspects of the coronary circulation.
Topics: Adenine Nucleotides; Angina Pectoris; Angiotensin II; Animals; Atrial Function; Blood Pressure; Coronary Disease; Coronary Vessels; Epinephrine; Histamine; Humans; Myocardium; Nitrates; Nitrites; Norepinephrine; Oxygen Consumption; Peptides; Piperazines; Prenylamine; Propranolol; Regional Blood Flow; Serotonin; Vasodilator Agents; Vasopressins; Verapamil | 1969 |
Vasodilator reserve, parallel vascular beds, and significant stenosis: a review for the angiographer.
Topics: Angiocardiography; Angiography; Angiotensin II; Animals; Arterial Occlusive Diseases; Cerebrovascular Disorders; Collateral Circulation; Contrast Media; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Extremities; Humans; Renal Artery Obstruction; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 1974 |
12 trial(s) available for angiotensin ii and Coronary Disease
Article | Year |
---|---|
[Preliminary exploration on effect of yiqi wenyang huoxue lishui treatment on neuroendocrine system in patients with congestive heart failure].
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Coronary Disease; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Middle Aged; Neurosecretory Systems; P-Selectin; Phytotherapy | 2002 |
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
Topics: Aged; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Biomarkers; Bradykinin; Cells, Cultured; Coronary Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Male; Microscopy, Fluorescence; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Perindopril; Proportional Hazards Models; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2007 |
Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?
Topics: Adult; Aged; Angiotensin II; Cardiac Output, Low; Coronary Disease; Endothelins; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies | 1994 |
Combining salicylate and enalapril in patients with coronary artery disease and heart failure.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Coronary Disease; Creatinine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Salicylates; Salicylic Acid | 1995 |
Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Coronary Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Natriuresis; Norepinephrine; Placebos; Renal Plasma Flow; Sodium | 1994 |
Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Drug Tolerance; Forearm; Humans; Male; Middle Aged; Nitroglycerin; Phenylephrine; Regional Blood Flow; Renin-Angiotensin System; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiac Catheterization; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Indoles; Lactic Acid; Male; Middle Aged; Norepinephrine; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Neuroendocrine activation in heart failure is modified by endurance exercise training.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Coronary Disease; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Neurosecretory Systems; Physical Endurance; Prognosis; Stroke Volume; Treatment Outcome; Vasopressins | 1999 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
Endothelium: a new target for cardiovascular therapeutics.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Vasodilation | 2000 |
Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Epinephrine; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Placebos; Renin; Time Factors; Vasopressins; Ventricular Function, Left | 1991 |
105 other study(ies) available for angiotensin ii and Coronary Disease
Article | Year |
---|---|
Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease.
Topics: Aged, 80 and over; Aldosterone; Angiotensin II; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Occlusion; Echocardiography; Female; Humans; Male; Malondialdehyde; Oxidative Stress; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
Angiotensin-Ⅱ and angiotensin-(1-7) imbalance affects comorbidity of depression and coronary heart disease.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Case-Control Studies; China; Comorbidity; Coronary Disease; Depression; Female; Gene Expression Regulation; Genotype; Humans; Linear Models; Male; Middle Aged; Peptide Fragments; Polymorphism, Single Nucleotide; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; ROC Curve; Signal Transduction; Surveys and Questionnaires | 2020 |
Re: Zhou Y, Zhang R, Wang G, et al. Coexistence effect of hypertension and angiotensin II on the risk of coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China. Curr Med Res Opin. 2019;35:1473-1478.
Topics: Angiotensin II; China; Cohort Studies; Coronary Disease; Humans; Hypertension; Prospective Studies | 2020 |
Association of angiotensin II type I and type II receptor genes polymorphisms with the presence of premature coronary disease and metabolic syndrome.
Topics: Adult; Alleles; Angiotensin II; Cholesterol; Coronary Disease; Genetic Predisposition to Disease; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Risk Factors | 2014 |
Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.
Topics: Aged; Angiotensin II; Animals; Coronary Disease; Endothelial Cells; Endothelium, Vascular; Female; Free Radical Scavengers; Gene Expression Regulation; Genes, Reporter; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypercholesterolemia; Immunity, Innate; Inflammasomes; Interleukin-1beta; Kruppel-Like Factor 4; Lipoproteins, LDL; Male; Mice; Mice, Transgenic; MicroRNAs; Middle Aged; Organometallic Compounds; Oxidative Stress; Recombinant Fusion Proteins; Salicylates; Sterol Regulatory Element Binding Protein 2; Transcriptional Activation; Zebrafish; Zebrafish Proteins | 2015 |
[IMPACT OF LONG-TERM ADAPTATION TO COLD ON THE STATE OF CARDIOVASCULAR SYSTEM].
Topics: Acclimatization; Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Arctic Regions; Cardiovascular Physiological Phenomena; Cardiovascular System; Catecholamines; Cold Temperature; Coronary Disease; Humans; Hypertension; Myocytes, Cardiac; Rats; Receptors, Adrenergic, alpha | 2015 |
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Body Weight; Coronary Disease; Coronary Vessels; Corticosterone; Cyclooxygenase 2; Diuresis; Drinking; Eating; Eplerenone; Heart; Hypertension; Isoenzymes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Necrosis; Organ Size; Osteopontin; Potassium; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Renin; Sialoglycoproteins; Sodium; Sodium Chloride; Spironolactone; Vasculitis | 2002 |
Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease.
Topics: Aged; Angiotensin II; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cells, Cultured; Coronary Disease; Gemfibrozil; Humans; Kidney Function Tests; Leukocytes, Mononuclear; Lipids; Liver Function Tests; Middle Aged; Tumor Necrosis Factor-alpha | 2003 |
[Microalbuminuria is an early marker for increased morbidity and mortality].
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke | 2003 |
Spinal cord activation differentially modulates ischaemic electrical responses to different stressors in canine ventricles.
Topics: Angiotensin II; Animals; Cardiac Pacing, Artificial; Constriction, Pathologic; Coronary Disease; Dogs; Electric Stimulation; Electroencephalography; Electrophysiology; Heart Ventricles; Spinal Cord; Ventricular Function | 2004 |
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Collagen Type I; Coronary Disease; Coronary Vessels; Fibrosis; Heart Ventricles; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 9; Mice; Mice, Obese; Obesity; Olmesartan Medoxomil; Phosphorylation; Plasminogen Activator Inhibitor 1; Tetrazoles; Thiazepines; Transforming Growth Factor beta | 2004 |
A new HOPE for aldosterone blockade?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Coronary Disease; Cytochrome P-450 CYP11B2; Drug Therapy, Combination; Endothelium, Vascular; Fibroblasts; Humans; Lipoproteins, LDL; Mice; Mice, Knockout; Mice, Transgenic; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nitric Oxide; Rats; Receptor, Angiotensin, Type 1; Receptors, LDL; Receptors, Mineralocorticoid; Receptors, Oxidized LDL; Recombinant Fusion Proteins; Renin; Scavenger Receptors, Class E; Signal Transduction | 2004 |
Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angiotensin I; Angiotensin II; Antihypertensive Agents; Coronary Disease; Drug Synergism; Female; Humans; Male; Myocardial Infarction; Nitric Oxide Donors; Nitroprusside; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasoconstrictor Agents | 2005 |
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
Topics: Aged; Aldosterone; Angiotensin II; Aorta; Aortic Valve Stenosis; Coronary Disease; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Stroke Volume; Venae Cavae | 2006 |
Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease.
Topics: Aged; Allopurinol; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cattle; Cells, Cultured; Coronary Circulation; Coronary Disease; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Losartan; Male; Middle Aged; NADPH Oxidases; Oxypurinol; Superoxides; Vasodilation; Xanthine Oxidase | 2007 |
Prostacyclin produced by the pericardium and its influence on coronary vascular tone.
Topics: Angiotensin II; Animals; Arachidonic Acids; Cattle; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Epoprostenol; Indomethacin; Muscle Tonus; Pericardial Effusion; Pericardium; Prostaglandins; Rats; Vasodilation | 1983 |
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Captopril; Chronic Disease; Coronary Disease; Dinoprostone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Proline; Prostaglandins E; Renin; Renin-Angiotensin System | 1983 |
[Guidelines for the performance of pharmacologic tests in the diagnosis and evaluation of ischemic cardiopathy. II. Study Group for the Functional Evaluation and Rehabilitation of the Cardiopathy Patient].
Topics: Angiotensin II; Coronary Disease; Dopamine; Humans; Isoproterenol | 1984 |
Synergistic relation between vasoconstriction and fixed epicardial vessel stenosis in coronary artery disease.
Topics: Acetylcholine; Angiotensin II; Animals; Arterial Occlusive Diseases; Coronary Disease; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Phenylephrine; Vasoconstriction | 1981 |
Angiotensin infusion effects on left ventricular function. Assessment in normal subjects and in patients with coronary disease.
Topics: Adult; Angiotensin II; Blood Pressure; Cardiac Output; Coronary Disease; Depression, Chemical; Heart; Heart Rate; Heart Ventricles; Humans; Infusions, Parenteral; Middle Aged; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Ventricular Function | 1980 |
Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease.
Topics: Acetylcholine; Angiotensin II; Animals; Calcium; Coronary Disease; Coronary Vessels; Death, Sudden; Dogs; Female; Magnesium; Magnesium Deficiency; Male; Norepinephrine; Potassium Chloride; Serotonin; Spasm; Vasomotor System | 1980 |
Coronary vascular hyperpermeability and angiotensin II.
Topics: Angiotensin II; Animals; Capillary Permeability; Coronary Disease; Coronary Vessels; Dinoprostone; Dogs; Fibronectins; Fibrosis; Gelatinases; Kinetics; Lymph; Male; Myocardium; Proteins; Serum Albumin | 1995 |
[From Thomas Lauder-Brunton to endogenous nitrates].
Topics: Amyl Nitrite; Angiotensin II; Coronary Disease; Endothelium, Vascular; History, 19th Century; History, 20th Century; Humans; Nitrates; Nitric Oxide; Thrombin | 1993 |
Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans.
Topics: Adult; Aged; Angiotensin II; Cardiac Output; Cardiac Pacing, Artificial; Catecholamines; Coronary Angiography; Coronary Disease; Female; Heart; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardial Ischemia; Neurosecretory Systems; Stroke Volume | 1994 |
The ACE gene: a cardiovascular risk factor.
Topics: Angiotensin II; Coronary Disease; Genes; Humans; Peptidyl-Dipeptidase A; Risk Factors | 1993 |
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Coronary Disease; Graft Rejection; Graft Survival; Heart Transplantation; Hyperplasia; Male; Mice; Mice, Inbred DBA; Myocardium; Tetrazoles; Transplantation, Homologous | 1996 |
[Clinical significance of fibrinolytic system defectiveness in exercise induced myocardial ischemia and its mechanism].
Topics: Angiotensin II; Coronary Disease; Exercise Test; Female; Humans; Male; Middle Aged; Plasminogen Inactivators; Renin-Angiotensin System; Tissue Plasminogen Activator | 1995 |
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Disease; Coronary Vessels; Disease Models, Animal; Imidazoles; Rats; Recurrence; Sulfonamides; Swine; Tetrazoles | 1996 |
Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Humans; Muscle, Smooth, Vascular; Recurrence; Renin-Angiotensin System | 1996 |
Isolation and characterisation of human cardiac fibroblasts from explanted adult hearts.
Topics: Adult; Angiotensin II; Cell Count; Cells, Cultured; Coronary Disease; DNA; Extracellular Matrix; Fibroblasts; Gene Expression; Heart Ventricles; Humans; Hypertension, Renovascular; Ligands; Myocardium; Phenotype; Receptors, Angiotensin | 1996 |
Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction.
Topics: Adult; Aged; Angiotensin II; Coronary Artery Bypass; Coronary Disease; Culture Techniques; Female; Heart Atria; Humans; Linear Models; Male; Middle Aged; Receptors, Angiotensin | 1996 |
Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Topics: Alleles; Angiotensin II; Asian People; Comorbidity; Coronary Disease; Diabetes Mellitus; Ethnicity; Female; Genetic Variation; Genotype; Humans; Hypercholesterolemia; Hypertension; Korea; Male; Mass Screening; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Risk Factors; Sequence Deletion; Sex Characteristics; Smoking | 1997 |
Family history in ischaemic heart disease.
Topics: Aged; Angiotensin II; Coronary Disease; Humans; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Risk Factors; Smoking | 1997 |
[The relationship between insulin resistance and angiotensin II and endothelins in patients with essential hypertension and coronary heart disease].
Topics: Adult; Aged; Angiotensin II; Blood Glucose; Coronary Disease; Endothelins; Female; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged | 1996 |
[Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Endothelin-1; Endothelium, Vascular; Humans; Nitric Oxide; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these dis
Topics: Aged; Angiotensin II; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Risk Factors | 1998 |
The role of angiotensin II AT1 receptor in the maintenance of hemodynamics in a canine model of coronary microembolization-induced heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzofurans; Blood Pressure; Coronary Disease; Dogs; Embolism; Female; Heart Failure; Heart Rate; Male; Receptors, Angiotensin | 1999 |
Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
Topics: Aged; Angiotensin II; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Risk | 1999 |
Pharmacological evaluation of a new laser blood flowmeter for measuring coronary blood flow, assessed in the canine isolated, blood-perfused ventricular tissue preparation in comparison with an electromagnetic flowmeter.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electromagnetic Phenomena; Female; Heart Ventricles; In Vitro Techniques; Laser-Doppler Flowmetry; Male; Myocardial Reperfusion; Oxygen Consumption; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Function | 1999 |
Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model.
Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cell Division; Coronary Disease; Coronary Vessels; Culture Techniques; Imidazoles; Losartan; Muscle, Smooth, Vascular; Pyridines; Recurrence; Swine; Tetrazoles | 1999 |
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis | 2000 |
The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Bradykinin; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Kidney; Lung; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neprilysin; Peptidyl-Dipeptidase A; Phenylalanine | 2000 |
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.
Topics: Aged; Angiotensin II; Coronary Disease; Female; Humans; Male; Mammary Arteries; Middle Aged; Saphenous Vein; Superoxides; Vasoconstrictor Agents | 2000 |
Association between the molecular pathobiology of essential hypertension and thrombotic diseases.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Coronary Disease; Disease Models, Animal; Humans; Hypertension; Mice; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thromboplastin; Thrombosis | 2000 |
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Coagulation Factors; Blood Pressure; Cell Line; CHO Cells; Coronary Disease; Coronary Vessels; Cricetinae; Extracellular Matrix Proteins; Heart Ventricles; Humans; Inflammation; Integrin alpha4beta1; Integrins; NF-kappa B; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Lymphocyte Homing; RNA, Messenger; Tetrazoles; Thromboplastin; Transcription Factor AP-1; Valine; Valsartan; Vascular Resistance | 2000 |
Endothelial dysfunction: the role and impact of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Endothelin-1; Endothelium, Vascular; Humans; Nitric Oxide; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System | 2000 |
New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Losartan; Male; Premedication; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic | 2000 |
[Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Coronary Disease; Endothelium, Vascular; Humans; Vasodilation | 2000 |
Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery.
Topics: Aged; Aged, 80 and over; Angiotensin II; Antibodies, Monoclonal; Chymases; Coronary Artery Bypass; Coronary Disease; Female; Humans; Immunoglobulin G; Male; Mammary Arteries; Middle Aged; Peptidyl-Dipeptidase A; Saphenous Vein; Serine Endopeptidases | 2001 |
Diastolic compliance of the left ventricle in man.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Angiotensin II; Aortic Valve Stenosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Diseases; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Mathematics; Middle Aged; Myocardial Contraction; Prognosis | 1975 |
Radionuclide left ventricular dV/dt for the assessment of cardiac function in patients with coronary disease.
Topics: Angiotensin II; Cardiac Volume; Coronary Disease; Heart; Humans; Kinetics; Male; Middle Aged; Physical Exertion; Posture; Radionuclide Imaging; Rest; Stroke Volume | 1979 |
[State of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Coronary Disease; Humans; Renin | 1978 |
[Changes of uptake of lactate due to ischemia indicated by atrial pacing and angiotensin].
Topics: Aged; Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Coronary Disease; Female; Heart Atria; Humans; Lactates; Male; Middle Aged; Myocardium | 1977 |
[Changes in uptake of lactate after angiotensin administration, atrial pacing and glucose infusions].
Topics: Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Coronary Disease; Glucose; Heart Atria; Humans; Lactates; Male; Middle Aged; Myocardium | 1977 |
[Changes in uptake of triglycerides due to ischemia induced by atrial pacing, angiotensin and glucose].
Topics: Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Coronary Disease; Glucose; Heart Atria; Myocardium; Triglycerides | 1977 |
[Changes in uptake of triglycerides due to ischemia induced by atrial pacing and angiotensin].
Topics: Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Coronary Disease; Heart Atria; Humans; Male; Middle Aged; Myocardium; Triglycerides | 1977 |
[CPK-MB enzyme changes in coronary disease patients given various types of algogenic treatment].
Topics: Adult; Aged; Angiotensin II; Cardiac Pacing, Artificial; Coronary Disease; Creatine Kinase; Female; Heart Atria; Humans; Isoenzymes; Male; Middle Aged | 1977 |
[Changes in NEFA uptake in patients with coronary disease after ischemia induced with atrial pacing and angiotensin].
Topics: Aged; Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Fatty Acids, Nonesterified; Heart Atria; Humans; Male; Middle Aged; Myocardium | 1977 |
Myocardial renin-angiotensin extraction in man.
Topics: Adult; Angiotensin II; Aorta; Coronary Disease; Coronary Vessels; Female; Humans; Male; Middle Aged; Myocardium; Renin | 1977 |
Contrasting influences of alterations in ventricular preload and afterload upon systemic hemodynamics, function, and metabolism of ischemic myocardium.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Cardiac Output; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Lactates; Myocardial Contraction; Myocardium; Vascular Resistance | 1977 |
Prostaglandins and the control of blood flow in the canine myocardium.
Topics: Adenosine; Angiotensin II; Animals; Arachidonic Acids; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Heart Rate; Hyperemia; Hypoxia; Indomethacin; Male; Meclofenamic Acid; Prostaglandin Antagonists; Prostaglandins; Prostaglandins E | 1977 |
Does low plasma renin activity indicate a favorable prognosis in hypertension?
Topics: Angiotensin II; Animals; Coronary Disease; Follow-Up Studies; Humans; Hypertension; Natriuresis; Prognosis; Renin | 1977 |
Preload, afterload, volume loading, pressure loading.
Topics: Angiotensin II; Animals; Cardiac Output; Coronary Disease; Dogs; Heart; Heart Rate; Myocardium; Oxygen Consumption | 1977 |
Dissociation between indices of pump performance and contractility in patients with coronary artery disease and acute myocardial infarction.
Topics: Acute Disease; Angiocardiography; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Exercise Test; Heart; Heart Rate; Heart Ventricles; Humans; Indicator Dilution Techniques; Models, Biological; Myocardial Infarction | 1975 |
The angiotensin infusion test as a method of evaluating left ventricular function.
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Cardiac Output; Coronary Disease; Evaluation Studies as Topic; Female; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged | 1975 |
[Renin-angiotensin-aldosterone system in hypertensive disease and arteriosclerotic myocardioslcerosis complicated by chronic circulatory insufficiency].
Topics: Aged; Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Renin | 1975 |
[State of the renin-angiotensin system in acute and chronic circulatory insufficiency].
Topics: Acute Disease; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Renin | 1975 |
Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.
Topics: Aged; Angiotensin I; Angiotensin II; Blood Pressure; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Vascular Resistance | 1992 |
Captopril inhibits angiotensin I-induced coronary flow reduction in isolated rat heart but has no effect on contractility or energy metabolism.
Topics: Adenosine Triphosphate; Angiotensin I; Angiotensin II; Animals; Captopril; Coronary Circulation; Coronary Disease; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Strains; Vasoconstriction | 1992 |
ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cold Temperature; Coronary Disease; Coronary Vessels; Diving; Humans; Middle Aged; Phentolamine; Reflex; Sympathetic Nervous System; Vasoconstriction | 1992 |
Exacerbation of ischemic dysfunction by angiotensin II in red cell-perfused rabbit hearts. Effects on coronary flow, contractility, and high-energy phosphate metabolism.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcium; Coronary Circulation; Coronary Disease; Energy Metabolism; Erythrocytes; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion; Phosphates; Phosphocreatine; Rabbits | 1992 |
Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts.
Topics: Angiotensin I; Angiotensin II; Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Heart; Hypoxia; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Saralasin; Vasoconstriction | 1991 |
[Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
Topics: Acute Disease; Angiotensin II; beta-Thromboglobulin; Coronary Disease; Epoprostenol; Fibrinopeptide A; Humans; Physical Exertion; Radioimmunoassay; Thromboxane A2; Vasopressins | 1991 |
Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANF.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Captopril; Coronary Circulation; Coronary Disease; Dogs; Renin-Angiotensin System; Saralasin; Vasoconstriction; Vasopressins | 1990 |
Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.
Topics: Angiotensin II; Animals; Captopril; Coronary Disease; Electric Stimulation; Electrophysiology; Hemodynamics; Male; Myocardial Infarction; Swine; Tachycardia | 1989 |
Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.
Topics: Angiotensin II; Animals; Aorta; Aprotinin; Captopril; Coronary Disease; Dogs; Myocardium; Nephrectomy; Radioimmunoassay | 1989 |
Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Female; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains | 1987 |
Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of myocardial ischaemia.
Topics: Administration, Cutaneous; Angiotensin II; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Delayed-Action Preparations; Disease Models, Animal; Dogs; Electrocardiography; Female; Heart Rate; Male; Nitroglycerin | 1989 |
[An examination of left ventricular peak filling rate and ventricular relaxation rate by simultaneous acquisition of radionuclide ventriculography and left ventricular pressure].
Topics: Adult; Angiotensin II; Blood Pressure; Cardiac Volume; Coronary Disease; Gated Blood-Pool Imaging; Heart; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Middle Aged; Stroke Volume | 1989 |
[Evaluation of left ventricular filling dynamics by pulsed Doppler echocardiography during afterload stress in ischemic heart disease using angiotensin II infusion].
Topics: Adult; Aged; Angiotensin II; Blood Flow Velocity; Coronary Disease; Echocardiography, Doppler; Female; Heart; Heart Atria; Heart Ventricles; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests | 1989 |
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Saralasin | 1989 |
[Direct cardiac effects of angiotensins I and II and 2 converting enzyme inhibitors (captopril and perindopril). Indirect demonstration of a converting enzyme in the rat heart].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Coronary Circulation; Coronary Disease; Heart; Heart Rate; Indoles; Male; Myocardium; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Saralasin | 1988 |
Hemodynamic effects of synthetic atrial natriuretic factor (ANF) in dogs with acute left ventricular failure.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Coronary Disease; Creatinine; Dogs; Electrolytes; Female; Heart Failure; Hemodynamics; Kidney Function Tests; p-Aminohippuric Acid; Renal Circulation; Time Factors | 1985 |
Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Coronary Circulation; Coronary Disease; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1988 |
Cardiac renin-angiotensin system. Molecular and functional aspects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Heart; Humans; Myocardial Contraction; Myocardium; Rats; Renin-Angiotensin System; Reperfusion Injury | 1988 |
Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Captopril; Coronary Circulation; Coronary Disease; Electrocardiography; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Norepinephrine; Rats; Rats, Inbred Strains | 1986 |
[Assessment of left ventricular function with the nuclear single probe and angiotensin II infusion].
Topics: Aged; Angiotensin II; Cardiac Output; Coronary Disease; Female; Heart; Heart Auscultation; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Technetium | 1986 |
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate; Humans; Isoproterenol; Mephentermine; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance | 1966 |
[Action of beta-angiotensin II on cardiac dynamics. Indirect study with the Blumberger method].
Topics: Adult; Aged; Angiotensin II; Coronary Disease; Heart; Hemodynamics; Humans; Middle Aged | 1967 |
[Behavior of coronary vascular resistance in experimental coronary insufficiency. Preliminary note].
Topics: Angiotensin II; Animals; Aorta; Blood Flow Velocity; Blood Pressure; Coronary Disease; Coronary Vessels; Dipyridamole; Dogs; Nitroglycerin; Vascular Resistance | 1967 |
[Evaluation of left ventricular efficiency during infusion of beta-angiotensin II. Studies with the polygraphic method].
Topics: Adult; Aged; Angiotensin II; Coronary Disease; Heart; Heart Function Tests; Heart Ventricles; Humans; Middle Aged | 1968 |
[Renin-angiotensin system in patients with circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Ascites; Coronary Disease; Diuretics; Edema; Endopeptidases; Humans; Juxtaglomerular Apparatus; Kidney; Renin; Rheumatic Heart Disease | 1968 |
Anaesthesia in patients with disturbances of cerebral and coronary circulation.
Topics: Anesthesia; Angiotensin II; Aortic Arch Syndromes; Cerebrovascular Disorders; Coronary Disease; Heart Aneurysm; Humans; Hypertension; Norepinephrine; Vena Cava, Superior | 1966 |
Myocardial function in patients with coronary artery disease.
Topics: Adolescent; Adult; Aged; Angiocardiography; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Male; Middle Aged; Stress, Physiological | 1969 |
[Antagonistic influencing of circulatory reactions following angiotensin and vasopressin in the anesthetized dog].
Topics: Acetylcholine; Amino Alcohols; Aminobenzoates; Angiotensin II; Animals; Benzoates; Coronary Disease; Coronary Vessels; Dilatation; Dipyridamole; Dogs; Guanethidine; Isoproterenol; Models, Biological; Nitroglycerin; Norepinephrine; Prenylamine; Propranolol; Strophanthins; Vasodilator Agents; Vasopressins | 1968 |
[Energy metabolism in the myocardium with coronary blood flow disorders].
Topics: Angina Pectoris; Angiotensin II; Animals; Coronary Disease; Dogs; Ischemia; Myocardium; Oxidative Phosphorylation | 1967 |
Ischemic heart disease and catecholamines.
Topics: Adult; Aged; Angina Pectoris; Angiotensin II; Blood Pressure; Catecholamines; Coronary Disease; Electrocardiography; Epinephrine; Exercise Test; Female; Heart Rate; Humans; Hypertension; Ischemia; Male; Middle Aged; Norepinephrine | 1971 |
[Myocardial contractility in coronary arteriosclerosis patients during repose, under auricular stimulation and under angiotensin perfusion].
Topics: Adult; Angiotensin II; Cardiac Catheterization; Cardiac Output; Coronary Disease; Female; Heart; Heart Atria; Heart Function Tests; Heart Rate; Heart Ventricles; Humans; Male; Methods; Middle Aged; Myocardium; Perfusion; Sex Factors | 1972 |
Comparison of isometric exercise and angiotensin infusion as stress test for evaluation of left ventricular function.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Coronary Disease; Evaluation Studies as Topic; Heart; Heart Diseases; Heart Rate; Humans; Myocardium; Oxygen Consumption; Physical Exertion; Stress, Physiological | 1973 |
Vasospasm in ischemic heart disease--a hypothesis.
Topics: Angina Pectoris; Angiotensin II; Animals; Arterial Occlusive Diseases; Blood Platelets; Catecholamines; Coronary Disease; Dogs; Female; Fibrinolysis; Humans; Male; Myocardial Infarction; Renin; Stress, Psychological | 1973 |
Pulmonary generation and peripheral uptake of endogenous angiotensin II in man.
Topics: Angiotensin II; Aorta; Coronary Disease; Coronary Vessels; Hepatic Veins; Humans; Liver Cirrhosis; Pulmonary Artery; Radioimmunoassay | 1973 |
Plasma angiotensin II activity in essential hypertension. Relation with vascular complications.
Topics: Adult; Aged; Angiotensin II; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hypertension; Ischemia; Male; Middle Aged | 1974 |
Characteristics of hypertension in the black population.
Topics: Adult; Angiotensin II; Animals; Black or African American; Cardiomegaly; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Guanethidine; Heart Ventricles; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; New York City; Rabbits; Radioimmunoassay; Renin; Sodium; Spironolactone | 1974 |
[Therapeutic progress in the area of arterial hypertension].
Topics: Adult; Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Belgium; Catecholamines; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Renin; Sympathetic Nervous System | 1974 |
Usefulness and limitations of circumferential fibre shortening velocity in evaluating segmental disorders of left ventricular contraction.
Topics: Adult; Angiotensin II; Cardiac Catheterization; Cineangiography; Coronary Disease; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Stenosis; Nitroglycerin; Time Factors | 1974 |